Live Breaking News & Updates on Dan Camardo

Stay updated with breaking news from Dan camardo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Athersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with Healios

The MOU includes $1.5M to $4.5M near term payments plus up to $150M in milestones

. ....

United States , Dan Camardo , Exchange Commission , Athersys Inc , Japan Pharmaceuticals , Devices Agency , Medical Devices Agency , Chief Executive Officer , Private Securities Litigation Reform Act , Texas Health Science Center , Annual Report ,

Athersys Licenses its Animal Health Assets to Ardent Animal Health

CLEVELAND & LEXINGTON, Ky. (BUSINESS WIRE) Athersys, Inc. (Nasdaq: ATHX), a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, and Multipotent Adult Progenitor Cell (MAPC®) technology for equine, canine, and feline health applications, announces the. ....

United States , Tirtht Patel , Thomas Masterson , Dan Camardo , Ellen Gurley , Ardent Animal Health , Corporate Communications , Athersys Inc , Multipotent Adult Progenitor Cell , Athersy Multipotent Adult Progenitor Cell , Secure Integrated Freezer Unit , Chief Executive Officer , Animal Health , Breakthru Portfolio , Private Securities Litigation Reform Act , Texas Health Science Center , Athersy Annual Report , Investor Relations ,

Athersys Director Jane Wasman Appointed Board Chair

CLEVELAND (BUSINESS WIRE) Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announces changes to its Board of Directors following the Company’s recent 2023 Annual Meeting of Stockholders. Current Director Jane Wasman, JD, has been ap. ....

United States , Ellen Gurley , Dan Camardo , Jane Wasman , Athersy Audit Committee , Athersys Inc , Sellas Life Sciences Nasdaq , Harvard Law School , Governance Compliance Committee , Exchange Commission , Plough Corporation , Princeton University , Rigel Pharmaceuticals Nasdaq , Corporate Communications , Current Director Jane Wasman , Board Chair , With Athersy , Chief Executive Officer , Athersys Board , Sellas Life Sciences , Rigel Pharmaceuticals , General Counsel , Acorda Therapeutics , Schering Plough Corporation , Vice President , Associate General ,

Athersys (ATHX) Licenses Animal Health Assets to Ardent Animal Health

Athersys (ATHX) Licenses Animal Health Assets to Ardent Animal Health
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Thomas Masterson , Dan Camardo , Ardent Animal Health , Athersys Inc , Multipotent Adult Progenitor Cell , Athersy Multipotent Adult Progenitor Cell , Secure Integrated Freezer Unit , Chief Executive Officer ,

Athersys Director Jane Wasman Appointed Board Chair

Athersys, Inc. , a regenerative medicine company developing MultiStem® for critical care indications, announces changes to its Board of Directors following the Company’s recent 2023 Annual. ....

United States , Dan Camardo , Jane Wasman , Rigel Pharmaceuticals Nasdaq , Governance Compliance Committee , Athersys Inc , Sellas Life Sciences Nasdaq , Athersy Audit Committee , Exchange Commission , Princeton University , Plough Corporation , Harvard Law School , Current Director Jane Wasman , Board Chair , With Athersy , Chief Executive Officer , Athersys Board , Sellas Life Sciences , Rigel Pharmaceuticals , General Counsel , Acorda Therapeutics , Schering Plough Corporation , Vice President , Associate General , Harvard Law , Private Securities Litigation Reform Act ,